-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Research Raises Genmab PT, Keeps Buy Rating

MT Newswires·10/07/2026 08:29:01
Listen to the news
08:29 AM EDT, 10/07/2026 (MT Newswires) -- Deutsche Bank Research on Tuesday raised the price target for Danish biotechnology company Genmab (GMAB.CO) to 2,750 Danish kroner from 2,500 kroner, while maintaining its buy rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)